Astellas — Drug Prices & Medicare Spending
Astellas manufactures 6 drugs tracked by Medicare Part D with total spending of $2.3B.
6
Drugs Tracked
$2.3B
Medicare Spending
$215.81
Avg Cost/Claim
100%
Have Generics
Astellas Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Myrbetriq | Mirabegron | $180.00 | Yes |
| 2 | Prograf | Tacrolimus | $229.00 | Yes |
| 3 | Xospata | Gilteritinib | $19,500.00 | Yes |
| 4 | Vesicare | Solifenacin | $94.00 | Yes |
| 5 | Cresemba | Isavuconazonium | $3,441.00 | Yes |
| 6 | Veozah | Fezolinetant | $206.00 | Yes |
Frequently Asked Questions
Astellas manufactures 6 drugs tracked by Medicare Part D, with total annual spending of $2.3B.
Xospata (Gilteritinib) is the most expensive at $19,500.00 per claim.
6 of 6 Astellas drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.